×
0 0 0 0 0 -0.390542907180385 -0.395796847635727 -0.395796847635727
Stockreport

Acorda Provides Update on Tozadenant Development Program

ACORDA THERAPEUTICS (ACOR)  More Company Research Source: Business Wire
Last acorda therapeutics earnings: 8/2 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF Identified cases of agranulocytosis, possibly drug-related, in some cases associated with sepsis and death Increased blood cell count monitoring to weekly in ongoing Phase 3 program Discussions with FDA and DSMB ongoing Conference call today at 8:30 a.m. ARDSLEY, N.Y.--(BUSINESS WIRE)-- Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that it has increased the frequency of blood cell count monitoring for participants to weekly in its Phase 3 program of tozadenant for Parkinson’s disease. The Company took this action in response to cases of agranulocytosis, possibly drug-related, and in some cases associated with sepsis and death. Agranulocytosis is the absence of white blood cells, which fight infection. The Company also has paused new enrollment in the long-term safety studies, pending further discussion with the independent Data Sa [Read more]

IMPACT SNAPSHOT EVENT TIME: ACOR
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
ACOR alerts
from News Quantified
Opt-in for
ACOR alerts

from News Quantified
Opt-in for
ACOR alerts

from News Quantified